tiprankstipranks
Takara Bio Inc. (JP:4974)
:4974
Japanese Market
4974
Takara Bio Inc.
RESEARCH TOOLSreports
Want to see JP:4974 full AI Analyst Report?

Takara Bio Inc. (4974) Financial Statements

2 Followers

Takara Bio Inc. Financial Overview

Takara Bio Inc.'s market cap is currently ¥137.76B. The company's EPS TTM is ¥-79.71; its P/E ratio is -14.40; and it has a dividend yield of 2.18%. Takara Bio Inc. is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 40.32B¥ 45.04B¥ 43.51B¥ 78.14B¥ 67.70B
Gross Profit¥ 20.26B¥ 26.07B¥ 26.91B¥ 44.77B¥ 49.21B
Operating Income¥ -4.69B¥ 2.26B¥ 3.00B¥ 20.54B¥ 28.90B
EBITDA¥ 633.00M¥ 6.50B¥ 7.90B¥ 25.98B¥ 31.70B
Net Income¥ -9.60B¥ 1.04B¥ 1.48B¥ 16.01B¥ 19.85B
Balance Sheet
Cash & Short-Term Investments¥ 20.45B¥ 29.55B¥ 35.42B¥ 51.85B¥ 23.63B
Total Assets¥ 133.66B¥ 127.61B¥ 123.21B¥ 129.20B¥ 115.71B
Total Debt¥ 10.98B¥ 1.10B¥ 968.00M¥ 972.00M¥ 1.05B
Net Debt¥ -9.47B¥ -28.45B¥ -34.45B¥ -50.88B¥ -22.59B
Total Liabilities¥ 29.69B¥ 11.76B¥ 11.42B¥ 16.75B¥ 19.65B
Stockholders' Equity¥ 103.67B¥ 115.50B¥ 111.50B¥ 112.22B¥ 95.87B
Cash Flow
Free Cash Flow¥ -8.99B¥ -4.03B¥ -11.07B¥ 31.15B¥ -5.55B
Operating Cash Flow¥ 3.58B¥ 5.84B¥ 1.71B¥ 36.90B¥ 6.99B
Investing Cash Flow¥ -18.68B¥ -10.91B¥ -13.04B¥ -6.69B¥ -7.07B
Financing Cash Flow¥ 6.12B¥ -2.26B¥ -5.23B¥ -4.12B¥ -2.07B
Currency in JPY

Takara Bio Inc. Earnings and Revenue History

Income Statement >

Takara Bio Inc. Debt to Assets

Balance Sheet >

Takara Bio Inc. Cash Flow

Cash Flow >

Takara Bio Inc. Forecast EPS vs Actual EPS

Earnings >